These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22770377)

  • 1. Protective effects of salidroside on epirubicin-induced early left ventricular regional systolic dysfunction in patients with breast cancer.
    Zhang H; Shen WS; Gao CH; Deng LC; Shen D
    Drugs R D; 2012 Jun; 12(2):101-6. PubMed ID: 22770377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of epirubicin-induced cardiotoxicity by two-dimensional strain echocardiography in breast cancer patients.
    Bi X; Deng Y; Zeng F; Zhu Y; Wu Y; Zhao C; Li C
    J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):391-4. PubMed ID: 19513629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer.
    Florescu M; Magda LS; Enescu OA; Jinga D; Vinereanu D
    J Am Soc Echocardiogr; 2014 Jan; 27(1):83-92. PubMed ID: 24268372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study.
    Gulati G; Heck SL; Røsjø H; Ree AH; Hoffmann P; Hagve TA; Norseth J; Gravdehaug B; Steine K; Geisler J; Omland T
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29118031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
    Mercuro G; Cadeddu C; Piras A; Dessì M; Madeddu C; Deidda M; Serpe R; Massa E; Mantovani G
    Oncologist; 2007 Sep; 12(9):1124-33. PubMed ID: 17914082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment.
    Cadeddu C; Piras A; Mantovani G; Deidda M; Dessì M; Madeddu C; Massa E; Mercuro G
    Am Heart J; 2010 Sep; 160(3):487.e1-7. PubMed ID: 20826257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of early epirubicin cardiotoxicity in women with breast cancer.
    Sobić-Saranović D; Pavlović S; Susnjar S; Neskovi c-Konstantinović Z; Jelić S
    Anticancer Res; 1997; 17(5B):3889-91. PubMed ID: 9427798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular diastolic performance in breast cancer survivors treated with anthracyclines.
    Radulescu D; Pripon S; Radulescu LI; Duncea C
    Acta Cardiol; 2008 Feb; 63(1):27-32. PubMed ID: 18372577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients.
    Michelotti A; Venturini M; Tibaldi C; Bengala C; Gallo L; Carnino F; Del Mastro L; Lionetto R; Montanaro E; Rosso R; Conte P
    Breast Cancer Res Treat; 2000 Jan; 59(2):133-9. PubMed ID: 10817348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early assessment of the left ventricular function by epirubicin-induced cardiotoxicity in postoperative breast cancer patients.
    Luo R; Cui H; Huang D; Li G
    Echocardiography; 2017 Nov; 34(11):1601-1609. PubMed ID: 28895191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-Doppler assessment of cardiac left ventricular function during short-term adjuvant epirubicin therapy for breast cancer.
    Appel JM; Sogaard P; Mortensen CE; Skagen K; Nielsen DL
    J Am Soc Echocardiogr; 2011 Feb; 24(2):200-6. PubMed ID: 21227647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for preventing anthracycline-induced clinical and subclinical cardiotoxicity: A network meta-analysis of metastatic breast cancer.
    Ghasemi K; Vaseghi G; Mansourian M
    J Oncol Pharm Pract; 2021 Mar; 27(2):414-427. PubMed ID: 33081570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer.
    Venturini M; Michelotti A; Del Mastro L; Gallo L; Carnino F; Garrone O; Tibaldi C; Molea N; Bellina RC; Pronzato P; Cyrus P; Vinke J; Testore F; Guelfi M; Lionetto R; Bruzzi P; Conte PF; Rosso R
    J Clin Oncol; 1996 Dec; 14(12):3112-20. PubMed ID: 8955656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salidroside from Rhodiola sachalinensis protects neuronal PC12 cells against cytotoxicity induced by amyloid-beta.
    Jang SI; Pae HO; Choi BM; Oh GS; Jeong S; Lee HJ; Kim HY; Kang KJ; Yun YG; Kim YC; Chung HT
    Immunopharmacol Immunotoxicol; 2003 Aug; 25(3):295-304. PubMed ID: 19180794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial.
    Nabati M; Janbabai G; Esmailian J; Yazdani J
    J Cardiovasc Pharmacol Ther; 2019 May; 24(3):233-241. PubMed ID: 30599756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
    Mantovani G; Madeddu C; Cadeddu C; Dessì M; Piras A; Massa E; Serpe R; Antoni G; Mercuro G
    Oncologist; 2008 Dec; 13(12):1296-305. PubMed ID: 19060235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Velocity vector imaging assessment of early epirubicin-induced myocardial damage].
    Jiang Y; Zhou Q; Tang Z; Peng Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):376-82. PubMed ID: 23645237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the epirubicin cardiotoxicity in cancer patients be prevented by angiotensin converting enzyme inhibitors?
    Radulescu D; Buzdugan E; Ciuleanu TE; Todor N; Stoicescu L
    J BUON; 2013; 18(4):1052-7. PubMed ID: 24344038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells.
    Zhang L; Yu H; Sun Y; Lin X; Chen B; Tan C; Cao G; Wang Z
    Eur J Pharmacol; 2007 Jun; 564(1-3):18-25. PubMed ID: 17349619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.
    de Azambuja E; Ameye L; Diaz M; Vandenbossche S; Aftimos P; Bejarano Hernández S; Shih-Li C; Delhaye F; Focan C; Cornez N; Vindevoghel A; Beauduin M; Lemort M; Paesmans M; Suter T; Piccart-Gebhart M
    Eur J Cancer; 2015 Nov; 51(17):2517-24. PubMed ID: 26321502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.